TCM Biotech International Corp.

4169 · TW · Healthcare / Biotechnology

121.50TWD+0.50 (+0.41%)

Price History

Full chart

Market Stats

Previous Close121.00

Open122.00

Day Range117.00 – 123.50

52-Week Range113.36 – 290.00

Volume191.67K

Market Cap10.02B

P/E (TTM)0.00

Forward P/E0.00

EPS-0.47

Dividend Yield0.21%

Beta0.11

50-Day Avg155.85

200-Day Avg177.12

About

TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for liver diseases. The company offers medical devices, such as therapy for osteoarthritis, intra-articular implant of hyaluronic acid, automated blood cell separator, absorbable adhesion barrier material, prosthetic and orthotic accessory, and pellefeel mask pressure relief pad; and pharmaceuticals, including iron supplement, therapeutic agent for urinary system, expectorant/mucolytic agent, anticancer drug, antihypertensive drug, and antidiabetic. It also provides medical detection platform for breast cancer recurrent risk detection and postoperative detection platform for liver cancer, as well as philips non-invasive positive pressure ventilation and accessories. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.

Company Details

SectorHealthcare
IndustryBiotechnology
CEODr. Ya-Chun Wang
Headquarters24Floor-8, No.97, Section 1, Taipei, Taiwan, 221416, Taiwan
Websitehttps://www.tcmbio.com

Leadership

Dr. Ya-Chun WangGM & Director
Xiu Ming WeiFinancial Manager
Shu Ya YangAccounting Manager
Bing Rong DuAdministration Department Manager
Prof. Pei-Jer Chen M.D., MBBS, Ph.D.Chief Advisor
Zhen Yao ChenVP of R&D and Chief Research and Development Officer

Financials

Income Statement

Currency: TWD	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	85.40M	144.57M	242.80M	281.07M	315.63M	314.11M	470.13M	505.86M	540.52M	540.23M	568.63M	737.08M	702.05M	802.42M	969.62M	666.53M	685.49M
Growth (%)	-	+69.30%	+67.94%	+15.76%	+12.30%	-0.48%	+49.67%	+7.60%	+6.85%	-0.05%	+5.26%	+29.62%	-4.75%	+14.30%	+20.84%	-31.26%	+2.84%
Cost of Revenue	55.00M	89.12M	154.43M	160.14M	160.34M	166.00M	303.62M	300.27M	302.36M	279.80M	295.33M	368.15M	343.33M	353.93M	489.45M	339.22M	388.82M
Gross Profit	30.40M	55.45M	88.37M	120.93M	155.29M	148.11M	166.51M	205.59M	238.16M	260.43M	273.30M	368.92M	358.72M	448.49M	480.17M	327.31M	296.68M
Gross Margin	35.60%	38.35%	36.40%	43.03%	49.20%	47.15%	35.42%	40.64%	44.06%	48.21%	48.06%	50.05%	51.10%	55.89%	49.52%	49.11%	43.28%
Operating Expense	54.02M	73.17M	106.43M	111.91M	143.09M	133.73M	149.54M	176.03M	208.73M	228.89M	259.59M	331.87M	356.59M	423.19M	457.84M	317.30M	278.02M
Operating Income	-23.62M	-17.72M	-18.06M	9.02M	12.20M	14.38M	16.97M	29.55M	29.43M	31.54M	13.71M	37.05M	2.13M	25.30M	22.33M	10.01M	18.65M
Operating Margin	-27.66%	-12.26%	-7.44%	3.21%	3.87%	4.58%	3.61%	5.84%	5.45%	5.84%	2.41%	5.03%	0.30%	3.15%	2.30%	1.50%	2.72%
EBITDA	-19.18M	-10.72M	-10.75M	17.69M	20.65M	22.62M	25.29M	36.98M	38.77M	44.13M	28.13M	53.15M	22.28M	45.51M	46.70M	50.49M	42.18M
EBITDA Margin	-22.46%	-7.42%	-4.43%	6.29%	6.54%	7.20%	5.38%	7.31%	7.17%	8.17%	4.95%	7.21%	3.17%	5.67%	4.82%	7.58%	6.15%
Net Income	-8.25M	-6.19M	10.80M	14.34M	16.02M	29.37M	20.76M	32.88M	18.93M	24.80M	6.51M	25.54M	1.87M	18.27M	18.57M	21.01M	19.17M
Net Income Margin	-9.67%	-4.28%	4.45%	5.10%	5.07%	9.35%	4.42%	6.50%	3.50%	4.59%	1.15%	3.47%	0.27%	2.28%	1.92%	3.15%	2.80%
R&D	26.55M	22.89M	14.24M	15.84M	31.86M	19.39M	19.80M	29.82M	32.47M	43.99M	44.63M	71.53M	80.45M	81.80M	77.46M	93.22M	88.42M
R&D as % of Total Revenue	31.09%	15.83%	5.86%	5.64%	10.09%	6.17%	4.21%	5.89%	6.01%	8.14%	7.85%	9.70%	11.46%	10.19%	7.99%	13.99%	12.90%
Interest Expense	1.10M	802.00K	36.00K	-	-	-	-	-	889.00K	1.87M	2.20M	1.95M	1.97M	2.38M	2.77M	1.61M	864.00K
Interest Expense % of Total Revenue	1.29%	0.55%	0.01%	-	-	-	-	-	0.16%	0.35%	0.39%	0.26%	0.28%	0.30%	0.29%	0.24%	0.13%

Balance Sheet

Currency: TWD	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	195.11M	235.82M	545.99M	554.88M	556.82M	601.79M	632.58M	638.68M	753.97M	808.81M	764.96M	772.26M	820.06M	862.87M	1.32B	1.18B	1.20B
Total Liabilities	81.90M	128.63M	182.51M	48.23M	51.32M	67.80M	106.52M	99.09M	226.16M	273.48M	254.24M	255.02M	301.84M	326.20M	267.88M	123.28M	148.86M
Total Equity	113.21M	107.18M	363.48M	506.65M	505.51M	534.00M	526.06M	539.59M	527.80M	535.34M	510.71M	517.24M	518.22M	536.67M	1.06B	1.06B	1.06B
Cash	17.48M	29.51M	31.60M	73.87M	45.91M	60.10M	125.93M	192.50M	53.07M	55.32M	120.72M	34.27M	58.26M	89.84M	504.13M	232.98M	245.07M
Total Debt	56.28M	10.00M	98.42M	7.70M	7.88M	11.80M	16.20M	19.44M	138.11M	164.92M	151.60M	138.95M	165.89M	171.14M	123.47M	51.04M	42.92M
Net Debt	38.80M	-19.51M	66.82M	-66.17M	-38.03M	-48.30M	-109.72M	-173.06M	85.04M	109.60M	30.88M	104.69M	107.63M	81.29M	-380.66M	-181.95M	-202.15M

Cash Flow

Currency: TWD	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-7.87M	-41.28M	-35.09M	16.53M	12.31M	49.52M	11.96M	-71.34M	62.54M	26.62M	-20.89M	74.90M	15.33M	52.24M	-37.54M	167.42M	38.99M
Investing Cash Flow	-17.24M	80.33M	8.55M	-124.56M	-23.72M	-33.97M	82.48M	157.14M	-288.36M	-33.32M	21.93M	-25.55M	-19.61M	-8.09M	-4.52M	-340.40M	3.04M
Financing Cash Flow	23.20M	-45.48M	329.20M	12.60M	-16.65M	-1.48M	-28.55M	-19.04M	86.44M	8.95M	-27.14M	-44.37M	28.24M	-12.44M	456.30M	-98.19M	-29.90M
Capital Expenditure	15.21M	3.02M	10.96M	781.00K	847.00K	2.61M	5.05M	1.98M	251.17M	57.92M	2.28M	21.68M	7.71M	5.29M	4.91M	8.36M	2.49M
Free Cash Flow	-23.07M	-44.31M	-46.05M	15.75M	11.47M	46.91M	6.91M	-73.32M	-188.63M	-31.30M	-23.16M	53.22M	7.61M	46.95M	-42.45M	159.07M	36.50M
Dividends Paid	-	-	-	-	16.65M	1.48M	28.55M	19.04M	29.98M	17.13M	17.86M	18.80M	16.92M	-	1.62M	16.83M	20.67M
FCF to OCF	293.38%	107.32%	131.23%	95.28%	93.12%	94.72%	57.76%	102.77%	-301.63%	-117.59%	110.90%	71.05%	49.67%	89.88%	113.08%	95.01%	93.62%
Dividend Paid to FCF	-	-	-	-	145.25%	3.16%	413.24%	-25.96%	-15.90%	-54.74%	-77.09%	35.32%	222.24%	-	-3.81%	10.58%	56.62%

Key Statistics & Ratios

Market Cap10.02B

Enterprise Value8.83B

Trailing P/E0.00

Forward P/E0.00

Price / Sales14.28

Price / Book5.12

EPS-0.47

Book Value29.42

Revenue (TTM)701.63M

Gross Profit (TTM)317.87M

EBITDA-21.03M

Profit Margin-4.49%

Operating Margin-5.81%

Return on Equity-2.09%

Return on Assets-1.46%

Shares Outstanding66.14M

Shares Float43.76M

Beta0.11

Dividend Yield0.21%

Dividend Rate0.32

Payout Ratio109.38%

Dividends

20261×

0.32Jul 20, 2026

20251×

0.35Aug 28, 2025

20241×

0.28Aug 28, 2024

20231×

0.03Jul 20, 2023

20211×

0.34Aug 26, 2021

20201×

0.37Aug 13, 2020

20191×

0.35Aug 6, 2019

20181×

0.34Aug 28, 2018

20171×

0.59Jul 27, 2017

20161×

0.37Aug 22, 2016

20151×

0.56Jul 16, 2015

20141×

0.03Aug 25, 2014

20131×

0.33Jul 15, 2013

Stock Splits

Jul 20, 20231030.6:1000
Aug 25, 20141028.8:1000